Meta Health Limited (SGX:5DX)
Singapore · Delayed Price · Currency is SGD 0.0040
0.00 (0.00%)
At close: Sep 9, 2026
Meta Health Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5 | 5 | 7 | 10 | 13 | 25 | |
Market Cap Growth | -50.00% | -28.57% | -28.27% | -20.83% | -47.23% | 186.74% |
Enterprise Value | 7 | 7 | 8 | 16 | 17 | 23 |
Last Close Price | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.04 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 21.26 |
Forward PE | - | 83.00 | 83.00 | 83.00 | 83.00 | 83.00 |
PS Ratio | 3.76 | 3.88 | 30.20 | 2.23 | 1.14 | 0.57 |
PB Ratio | -2.75 | -3.59 | -4.38 | -20.90 | 2.60 | 1.56 |
P/TBV Ratio | - | - | - | - | 2.57 | 1.56 |
P/OCF Ratio | - | - | - | - | - | 85.27 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.19 | 5.10 | 34.22 | 3.49 | 1.47 | 0.53 |
EV/EBITDA Ratio | - | - | - | - | - | 17.39 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -1.25 | -1.48 | -1.35 | -8.03 | 1.66 | 0.61 |
Debt / EBITDA Ratio | - | - | - | - | - | 3.46 |
Net Debt / Equity Ratio | -1.11 | -1.33 | -1.22 | -1.18 | 0.85 | -0.11 |
Net Debt / EBITDA Ratio | -2.31 | -1.75 | -4.53 | -0.21 | -1.19 | -1.30 |
Net Debt / FCF Ratio | -30.26 | -2.08 | -1.88 | -0.22 | -1.55 | 20.57 |
Asset Turnover | 0.81 | 0.80 | 0.05 | 0.31 | 0.37 | 1.03 |
Inventory Turnover | - | - | - | 2.27 | 2.54 | 5.90 |
Quick Ratio | 0.40 | 0.46 | 0.42 | 0.65 | 0.83 | 1.24 |
Current Ratio | 0.41 | 0.47 | 0.42 | 1.13 | 1.11 | 1.49 |
Return on Equity (ROE) | - | - | - | -147.77% | -70.65% | 7.79% |
Return on Assets (ROA) | -33.32% | -41.37% | -6.03% | -11.61% | -9.59% | -0.04% |
Return on Invested Capital (ROIC) | - | - | - | -54.66% | -40.80% | -0.16% |
Return on Capital Employed (ROCE) | 49.50% | 86.70% | 36.80% | -273.00% | -56.00% | -0.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -21.18% | -23.64% | -19.49% | -81.56% | -66.48% | 4.70% |
FCF Yield | -1.33% | -17.84% | -14.78% | -25.71% | -21.05% | -0.33% |
Buyback Yield / Dilution | -36.30% | -23.82% | -60.60% | -18.55% | -32.45% | -12.01% |